 |
|
Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line
Ankita Makol, Harpreet Kaur, Sakshi Sharma, Shruthi Kanthaje, Ramanpreet Kaur, Anuradha Chakraborti
Clin Mol Hepatol. 2020;26(1):45-53. Published online 2019 Sep 30 DOI: https://doi.org/10.3350/cmh.2019.0031
|
|
Citations to this article as recorded by
 Withanolides: Promising candidates for cancer therapy
Qiang Zhang, YongKang Yuan, Shijie Cao, Ning Kang, Feng Qiu
Phytotherapy Research.2024; 38(2): 1104. CrossRef Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma
Mukesh Kumar, Ramanpreet Kaur, Shruthi Kanthaje, Radha K. Dhiman, Anuradha Chakraborti
Journal of Cancer Research and Clinical Oncology.2023; 149(9): 5823. CrossRef Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
Zhichao Xing, Anping Su, Li Mi, Yujie Zhang, Ting He, Yuxuan Qiu, Tao Wei, Zhihui Li, Jingqiang Zhu, Wenshuang Wu
Drug Design, Development and Therapy.2023; Volume 17: 2909. CrossRef Molecular targets and mechanisms of anti-cancer effects of withanolides
Zhiruo Zhang, Yueying Yang, Yang Xu, Yang Liu, Hua Li, Lixia Chen
Chemico-Biological Interactions.2023; 384: 110698. CrossRef Label-Free Quantitative Proteomics Analysis of the Sorafenib Resistance in HepG2 Cells
Zi-Xuan Wang, Hong-Wei Chu, Kai-Guang Yang, Bao-Feng Zhao, Zhen Liang, Li-Hua Zhang, Yu-Kui Zhang
Journal of Analysis and Testing.2022; 6(3): 308. CrossRef Role of ATP-binding Cassette Transporters in Sorafenib Therapy for Hepatocellular
Carcinoma: An Overview
Maria Manuela Estevinho, Carlos Fernandes, João Carlos Silva, Ana Catarina Gomes, Edgar Afecto, João Correia, João Carvalho
Current Drug Targets.2022; 23(1): 21. CrossRef Feedback regulation of antioxidant transcription factor NFE2L1 and immunostimulatory factor 41BBL mediates the crosstalk between oxidative stress and tumor immunity
Lu Qiu, Haoming Ning, Yaqian Zhu, Qiufang Yang, Lulu Liu, Lei Luo, Yanfeng Gao, Yadi Xing
Molecular Immunology.2022; 141: 265. CrossRef miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line
Ramanpreet Kaur, Shruthi Kanthaje, Sunil Taneja, Radha K. Dhiman, Anuradha Chakraborti
Genes.2022; 13(8): 1375. CrossRef MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Tong-tong Li, Jie Mou, Yao-jie Pan, Fu-chun Huo, Wen-qi Du, Jia Liang, Yang Wang, Lan-sheng Zhang, Dong-sheng Pei
Journal of Biomedical Science.2021;[Epub] CrossRef Exacerbation of Liver Tumor Metastasis in twist1a+/xmrk+ Double Transgenic Zebrafish following Lipopolysaccharide or Dextran Sulphate Sodium Exposure
Jeng-Wei Lu, Yuxi Sun, Liang-In Lin, Dong Liu, Zhiyuan Gong
Pharmaceuticals.2021; 14(9): 867. CrossRef Circulating Tumor Cells Expressing Krüppel-Like Factor 8 and Vimentin as Predictors of Poor Prognosis in Pancreatic Cancer Patients
Peng Zhu, Hui-Ying Liu, Fu-Chen Liu, Fang-Ming Gu, Sheng-Xian Yuan, Jian Huang, Ze-Ya Pan, Wei-Jun Wang
Cancer Control.2021; 28: 107327482110271. CrossRef The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
Zhongqiang Zhang, Xiao Tan, Jing Luo, Hongliang Yao, Zhongzhou Si, Jing-Shan Tong
Cell Death & Disease.2020;[Epub] CrossRef Reactive oxygen species-induced activation of Yes-associated protein-1 through the c-Myc pathway is a therapeutic target in hepatocellular carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Sun Woong Kim, Wonjin Kim, Sooyeon Oh, Joo Ho Lee
World Journal of Gastroenterology.2020; 26(42): 6599. CrossRef Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells
Kosha J. Mehta, Paul A. Sharp
Scientific Reports.2020;[Epub] CrossRef
|